title: Clinical efficacy of two different drug combinations for the treatment of canine leishmaniasis.
authors.affiliation: Dipartimento di Sanità Pubblica Veterinaria, Università degli Studi di Messina, Messina, Italy. mariagrazia.pennisi@unime.it
authors.forename: M G
authors.initials: MG
authors.lastname: Pennisi
authors.forename: S
authors.initials: S
authors.lastname: Lo Giudice
authors.forename: M
authors.initials: M
authors.lastname: Masucci
authors.forename: M
authors.initials: M
authors.lastname: De Majo
authors.forename: S
authors.initials: S
authors.lastname: Reale
authors.forename: F
authors.initials: F
authors.lastname: Vitale
mesh_terms: D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D004283:Dog Diseases / Q000188:drug therapy* / Q000469:parasitology*; D004285:Dogs; D004359:Drug Therapy, Combination; D007896:Leishmaniasis / Q000188:drug therapy / Q000662:veterinary*; D008536:Meglumine / Q000627:therapeutic use*; D000077485:Meglumine Antimoniate; D008795:Metronidazole / Q000627:therapeutic use*; D009942:Organometallic Compounds / Q000627:therapeutic use*; D015572:Spiramycin / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000913:Antibodies, Protozoan; D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008795:Metronidazole; D008536:Meglumine; D000077485:Meglumine Antimoniate; D015572:Spiramycin